BRPI0406931A - Método para a produção de um coagulante a partir de sangue total anticoagulado, kit para a preparação de um coagulante a partir de sangue total anticoagulado, e, fração de sangue humano - Google Patents

Método para a produção de um coagulante a partir de sangue total anticoagulado, kit para a preparação de um coagulante a partir de sangue total anticoagulado, e, fração de sangue humano

Info

Publication number
BRPI0406931A
BRPI0406931A BR0406931-5A BRPI0406931A BRPI0406931A BR PI0406931 A BRPI0406931 A BR PI0406931A BR PI0406931 A BRPI0406931 A BR PI0406931A BR PI0406931 A BRPI0406931 A BR PI0406931A
Authority
BR
Brazil
Prior art keywords
coagulant
blood
whole blood
anticoagulated whole
anticoagulated
Prior art date
Application number
BR0406931-5A
Other languages
English (en)
Inventor
Sherwin V Kevy
Sheryl Sullivan
May Jacobson
Lou Blasetti
Original Assignee
Harvest Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvest Technologies Inc filed Critical Harvest Technologies Inc
Publication of BRPI0406931A publication Critical patent/BRPI0406931A/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6429Thrombin (3.4.21.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21005Thrombin (3.4.21.5)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497Preparation composition [e.g., lysing or precipitation, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Ecology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)

Abstract

"MéTODO PARA A PRODUçãO DE UM COAGULANTE A PARTIR DE SANGUE TOTAL ANTICOAGULADO, KIT PARA A PREPARAçãO DE UM COAGULANTE A PARTIR DE SANGUE TOTAL ANTICOAGULADO, E, FRAçãO DE SANGUE HUMANO". Um método para a preparação de um coagulante homólogo ou autólogo de sangue total é descrito. A precipitação direta de sangue total anticoagulado evita a necessidade de uma etapa de isolamento de plasma com resultados inesperados. O coagulante homólogo ou autólogo produzido pelo método da presente invenção demonstrou tempos de coagulação equivalentes aos das preparações de trombina humana e de trombina bovina comercialmente disponiveis, com cinética melhorada de liberação de fator de crescimento das plaquetas ativadas sobre as preparações de trombina bovina.
BR0406931-5A 2003-01-27 2004-01-27 Método para a produção de um coagulante a partir de sangue total anticoagulado, kit para a preparação de um coagulante a partir de sangue total anticoagulado, e, fração de sangue humano BRPI0406931A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44297403P 2003-01-27 2003-01-27
PCT/US2004/002191 WO2004068109A2 (en) 2003-01-27 2004-01-27 Autologous or homologous coagulant produced from anticoagulated whole blood

Publications (1)

Publication Number Publication Date
BRPI0406931A true BRPI0406931A (pt) 2006-01-03

Family

ID=32825282

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0406931-5A BRPI0406931A (pt) 2003-01-27 2004-01-27 Método para a produção de um coagulante a partir de sangue total anticoagulado, kit para a preparação de um coagulante a partir de sangue total anticoagulado, e, fração de sangue humano

Country Status (11)

Country Link
US (1) US20040208786A1 (pt)
EP (1) EP1599715A2 (pt)
JP (1) JP2006516630A (pt)
KR (1) KR20050105184A (pt)
CN (2) CN101317855A (pt)
AU (1) AU2004207261B2 (pt)
BR (1) BRPI0406931A (pt)
CA (1) CA2514001A1 (pt)
IL (1) IL169792A0 (pt)
MX (1) MXPA05007888A (pt)
WO (1) WO2004068109A2 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060094865A1 (en) * 2004-10-29 2006-05-04 Kapur Terri A Intraoperative method for isolating and concentrating autologous growth factors and for forming residual autologous growth factor compositions
RU2009141918A (ru) * 2007-04-18 2011-05-27 H2Q Уотер Индастриз Лтд. (Il) Фильтровальная среда
WO2012048298A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
EP2806914B1 (en) 2012-01-23 2021-09-22 Estar Technologies Ltd A system and method for obtaining a cellular sample enriched with defined cells such as platelet rich plasma(prp)
CA2868862C (en) * 2012-09-25 2017-06-27 Stem Cell Partners Llc Method and apparatus for preparing single donor thrombin serum
EP3068867B1 (en) 2013-11-16 2018-04-18 Terumo BCT, Inc. Expanding cells in a bioreactor
WO2015148704A1 (en) 2014-03-25 2015-10-01 Terumo Bct, Inc. Passive replacement of media
CN106715676A (zh) 2014-09-26 2017-05-24 泰尔茂比司特公司 按计划供养
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
CA3046406C (en) * 2017-02-09 2024-01-30 Csl Behring Gmbh A blood coagulation factor replacement product for use in the treatment or prophylaxis of bleedings
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
WO2018184028A2 (en) 2017-03-31 2018-10-04 Terumo Bct, Inc. Cell expansion
CA3127191A1 (en) 2019-01-21 2020-07-30 Eclipse Medcorp, Llc Methods, systems and apparatus for separating components of a biological sample
CN110361531B (zh) * 2019-08-02 2023-04-11 天津医科大学总医院 一种检测微粒促凝活性的实验方法
CA3159372A1 (en) 2019-10-31 2021-05-06 Eclipse Medcorp, Llc Systems, methods and apparatus for separating components of a sample
CN112841171A (zh) * 2021-01-12 2021-05-28 广州鸿泉生物科技有限公司 用于血栓试验中的抗凝猪血、猪血浆的制备方法及应用
JP2024511064A (ja) 2021-03-23 2024-03-12 テルモ ビーシーティー、インコーポレーテッド 細胞捕獲及び増殖
JP2023047560A (ja) * 2021-09-27 2023-04-06 国立大学法人 東京大学 細胞培養用成分、細胞培養用培地、血清の製造方法、及び、細胞の製造方法
CN115825263A (zh) * 2022-11-04 2023-03-21 南京科技职业学院 一种血清中氧化型白蛋白的检测方法及其试剂盒

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4359463A (en) * 1980-11-26 1982-11-16 Rock Gail A Stabilization of Factor VIII activity in whole blood or blood plasma
DE3366540D1 (en) * 1982-04-28 1986-11-06 Trustees Of The Garfield Westo Processes for the production of blood products
US4675385A (en) * 1985-03-27 1987-06-23 Alpha Therapeutic Corporation Isolation of human plasma procoagulant protein factor VIII from biological factors
JPS6360931A (ja) * 1986-08-29 1988-03-17 Noboru Sato 血液または血液製剤保存液およびこれを用いた血液または血液製剤の保存方法
US5135875A (en) * 1990-08-15 1992-08-04 Abbott Laboratories Protein precipitation reagent
SE9403833D0 (sv) * 1994-11-08 1994-11-08 Global Hemostasis Inst Mgr Ab Analysförfarande och kit
US5510102A (en) * 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives
US6320029B1 (en) * 1996-11-29 2001-11-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
CA2257791A1 (en) * 1996-05-24 1997-11-27 Thermogenesis Corp. Fibrinogen apparatus, method and container
US5783447A (en) * 1996-10-02 1998-07-21 University Of Medicine And Dentistry Of New Jersey Hypercoagulability comparative determinants obtained using detection systems with variable force-induced energy inputs
US5783093A (en) * 1997-01-02 1998-07-21 Haemonetics Corporation Blood cell concentrates using a single solution for anticoagulation and preservation
US6274090B1 (en) * 1998-08-05 2001-08-14 Thermogenesis Corp. Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
US6472162B1 (en) * 1999-06-04 2002-10-29 Thermogenesis Corp. Method for preparing thrombin for use in a biological glue
KR100880622B1 (ko) * 2000-06-29 2009-01-30 바이오신텍 캐나다 인코포레이티드 연골 및 다른 조직의 복구 및 재생용 조성물 및 방법
EP1459724B1 (en) * 2001-12-28 2013-11-20 Terumo Kabushiki Kaisha Blood bag system and method of inactivating pathogenic microorganisms
US20040120942A1 (en) * 2002-12-23 2004-06-24 Mcginnis Daniel Device and process for the preparation of autologous thrombin serum

Also Published As

Publication number Publication date
AU2004207261B2 (en) 2009-07-09
WO2004068109A3 (en) 2005-10-27
IL169792A0 (en) 2007-07-04
EP1599715A2 (en) 2005-11-30
JP2006516630A (ja) 2006-07-06
CN101317855A (zh) 2008-12-10
CN1764372A (zh) 2006-04-26
KR20050105184A (ko) 2005-11-03
CN100415093C (zh) 2008-09-03
AU2004207261A1 (en) 2004-08-12
US20040208786A1 (en) 2004-10-21
CA2514001A1 (en) 2004-08-12
MXPA05007888A (es) 2005-12-15
WO2004068109A2 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
BRPI0406931A (pt) Método para a produção de um coagulante a partir de sangue total anticoagulado, kit para a preparação de um coagulante a partir de sangue total anticoagulado, e, fração de sangue humano
RU2735139C2 (ru) Полученные из лизата тромбоцитов человека внеклеточные везикулы для применения в медицине
ATE458754T1 (de) Screening-verfahren, verfahren zur aufreinigung nichtdiffundierbarer a-beta-oligomere, selektive antikörper gegen diese nichtdiffundierbaren a- beta-oligomere und verfahren zur herstellung dieser antikörper
ATE489119T1 (de) Plasmaprotein-matritzes und verfahren zu ihrer herstellung
ATE373018T1 (de) Esterderivate von hyaluronsäure zur herstellung von hydrogelmaterialien durch photohärtung
ATE455463T1 (de) Verfahren zur herstellung gefriergetrockneter blutplättchen, gefriergetrocknete blutplättchen enthaltende zusammensetzungen und verwendungsverfahren
ATE349903T1 (de) Verfahren zur gewinnung von kaseinfraktionen aus milch und kaseinaten und herstellung neuer produkte
ATE512153T1 (de) Salz einer sulfonsäure mit clopidogrel und dessen verwendung zur herstellung pharmazeutischer formulierungen
BRPI0514236A (pt) composto, uso do mesmo, composição farmacêutica, e, métodos para produzir 17-desmetilrapamicina ou um análogo da mesma, para gerar uma cepa recombinante, para preparar um análogo de 17-desmetilrapamicina e para gerar um análogo de 17-desmetilrapamicina
ATE452145T1 (de) Verfahren zur herstellung von peptidderivaten
ATE517607T1 (de) Verfahren zur herstellung von partikeln zur verwendung in einer pharmazeutischen zusammensetzung
WO2004084825A3 (en) Wound healing composition derived from low platelet concentration plasma
ES2173812A1 (es) Dermis artificial y metodo de obtencion.
WO2000056885A1 (en) Protein for blocking platelet adhesion
FI95136B (fi) Menetelmä anneksiinien puhdistamiseksi
DE60236667D1 (de) System zur Herstellung eines Gels aus autologen Blutplättchen
IL158082A0 (en) Amlodipine camsylate and methods for the preparation thereof
WO2006008748A3 (en) Porous plasma protein matrices and methods for preparation thereof
Michaud et al. Purification of salmon thrombin and its potential as an alternative to mammalian thrombins in fibrin sealants
DE50210646D1 (de) Verfahren zur herstellung von implantaten mittels lösungsmittelfreier herstellung eines homogenisats
BR112012011894A2 (pt) "composição de enxerto para a regeneração de tecido neural, método de produção e usos destes".
WO2008081818A1 (ja) 皮膚組織改善材およびその製造方法
Rosetti et al. Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines
ES2221770B2 (es) Metodo de preparacion de un compuesto para la regeneracion de tejidos.
FI93697B (fi) Menetelmä trombiinia inhiboivan vaikutuksen omaavan amblyommiinin eristämiseksi

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.